What is the recommended management for cellulitis?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: July 9, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Management of Cellulitis

For uncomplicated cellulitis, a 5-day course of antibiotics active against streptococci is recommended as first-line therapy, with extension only if the infection has not improved within this time period. 1

Diagnosis

Cellulitis is a bacterial infection of the deep dermis and subcutaneous tissue, presenting with:

  • Expanding erythema
  • Warmth
  • Tenderness
  • Swelling

Diagnostic workup:

  • Cultures of blood, tissue aspirates, or skin biopsies are not routinely recommended for typical cases 1
  • Blood cultures should be obtained in patients with:
    • Malignancy
    • Severe systemic features (high fever, hypotension)
    • Unusual predisposing factors (immersion injury, animal bites)
    • Neutropenia
    • Severe cell-mediated immunodeficiency 1

Antibiotic Therapy

First-line treatment (typical cellulitis):

  • Antibiotic active against streptococci 1
  • Suitable oral options include:
    • Penicillin
    • Amoxicillin
    • Amoxicillin-clavulanate
    • Dicloxacillin
    • Cephalexin
    • Clindamycin 1

Duration:

  • 5 days of antimicrobial therapy is as effective as a 10-day course if clinical improvement has occurred by day 5 1, 2
  • Treatment should be extended if the infection has not improved within this period 1

MRSA considerations:

  • MRSA is an unusual cause of typical cellulitis 1
  • Coverage for MRSA should be considered in cellulitis associated with:
    • Penetrating trauma (especially from illicit drug use)
    • Purulent drainage
    • Concurrent evidence of MRSA infection elsewhere
    • Nasal colonization with MRSA
    • Injection drug use
    • Systemic inflammatory response syndrome (SIRS) 1

Parenteral therapy indications:

  • Severely ill patients
  • Patients unable to tolerate oral medications
  • Options include:
    • Nafcillin
    • Cefazolin
    • Clindamycin or vancomycin (for patients with life-threatening penicillin allergies) 1

Adjunctive Measures

  1. Elevation of the affected area to promote gravity drainage of edema and inflammatory substances 1

  2. Treatment of predisposing factors:

    • Tinea pedis
    • Venous eczema/stasis dermatitis
    • Trauma
    • Edema
    • Obesity
    • Underlying cutaneous disorders 1
  3. Consider systemic corticosteroids (prednisone 40 mg daily for 7 days) in non-diabetic adult patients with cellulitis 1

Hospitalization Criteria

Hospitalization is recommended if:

  • Concern for deeper or necrotizing infection
  • Poor adherence to therapy
  • Infection in a severely immunocompromised patient
  • Outpatient treatment is failing
  • SIRS
  • Altered mental status
  • Hemodynamic instability 1

Prevention of Recurrent Cellulitis

For patients with 3-4 episodes of cellulitis per year despite treatment of predisposing factors, consider prophylactic antibiotics:

  • Oral penicillin or erythromycin twice daily for 4-52 weeks
  • Intramuscular benzathine penicillin every 2-4 weeks 1

Special Considerations

  • In lower-extremity cellulitis, carefully examine interdigital toe spaces as treating fissuring, scaling, or maceration may eradicate colonization with pathogens and reduce recurrence 1

  • For recurrent cellulitis, addressing predisposing factors is crucial, including:

    • Lymphedema
    • Venous insufficiency
    • Obesity
    • Toe web abnormalities 1
  • Treatment failure should prompt consideration of:

    • Resistant organisms
    • Secondary conditions mimicking cellulitis
    • Underlying complicating conditions (immunosuppression, chronic liver disease, chronic kidney disease) 3

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Cellulitis: A Review.

JAMA, 2016

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.